Cargando…
Thymoquinone as a Potential Adjuvant Therapy for Cancer Treatment: Evidence from Preclinical Studies
Thymoquinone (TQ), the main bioactive component of Nigella sativa, has been found to exhibit anticancer effects in numerous preclinical studies. Due to its multitargeting nature, TQ interferes in a wide range of tumorigenic processes and counteracts carcinogenesis, malignant growth, invasion, migrat...
Autores principales: | Mostofa, A.G.M., Hossain, Md Kamal, Basak, Debasish, Bin Sayeed, Muhammad Shahdaat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466966/ https://www.ncbi.nlm.nih.gov/pubmed/28659794 http://dx.doi.org/10.3389/fphar.2017.00295 |
Ejemplares similares
-
Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways
por: Chowdhury, Fabliha Ahmed, et al.
Publicado: (2018) -
Therapeutic Potential and Pharmaceutical Development of Thymoquinone: A Multitargeted Molecule of Natural Origin
por: Goyal, Sameer N., et al.
Publicado: (2017) -
Phytosterols: From Preclinical Evidence to Potential Clinical Applications
por: Salehi, Bahare, et al.
Publicado: (2021) -
Indian Medicinal Plants and Formulations and Their Potential Against COVID-19–Preclinical and Clinical Research
por: Ahmad, Sayeed, et al.
Publicado: (2021) -
Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence
por: Lin, Shian‐Ren, et al.
Publicado: (2019)